Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00720720
Other study ID # 2006-03
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date December 16, 2009
Est. completion date February 24, 2010

Study information

Verified date September 2023
Source French Cardiology Society
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this exploratory study is to analyse in humans any qualitative changes of carotid artery atherosclerotic plaque under the influence of plant sterols consumption.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date February 24, 2010
Est. primary completion date February 24, 2010
Accepts healthy volunteers No
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria: - Patient, men and women, aged between 40 to 75 ans (limits included) willing to participate to the study and have signed informed consent for its participation in the study - Displaying a non serious chirurgical indication of clinical asymptomatic carotid stenosis defined by: - atherosclerotic stenosis of 60 to 75% on one on the two carotid junction (external carotid excluded) according to criteria from NASCET - without constituted or transitory recent cerebral vascular accident. The discovery of an ischaemic after-effect on a systematic scanner is not a criterion of exclusion - Subject with normal body weight or in over weight (Body Mass Index ranged between 19 and 30 kg/m2, [limits included]) - Subject willing to follow dietary recommendations advised during hypercholesterolemia (according to AFSSAPS' recommendations) - Subject with social insurance or equivalent. Exclusion Criteria: - Subject who, according to AFSSAPS' recommendations, should received a hypocholesterolemic therapy before the end of the study. - Subject with a history of diabetes - Subject with cardiac disease such as unstable angina, myocardial infarction, coronary angioplasty, coronary artery bypass graft surgery, or moderate or severe congestive heart failure within the last 6 months. - Subject with plasma triglyceride levels higher than 2,5 g/l [limit included], - Subject taking any drugs known to affect the evaluation of studied parameters - Subject with severe or acute disease that could affect the results of the study or subject safety - Subject with regular consumption of phytosterol enriched foods products during the study. - Subject with any other medical condition or laboratory abnormality prior to recruitment that in the opinion of the principal investigator could affect subject safety or render unlikely trial to be conducted to the end. - For women: pregnancy or breast feeding or subject likely to be pregnant during the study. - For women: subject likely to modify their hormonal therapy during the study - Subject in exclusion period after its participation in an other clinical trial

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
plant sterol enriched margarine
Each group will have to consume 20 grams of margarines (either placebo or enriched in plant sterols) in one or two catches per day, for 8 weeks.
placebo margarine


Locations

Country Name City State
France Hôpital cardio-vasculaire et pneumologique Louis Pradel Bron
France Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition Nantes
France Groupe Hospitalier Pitié-Salpêtrière, Endocrinology and Metabolism Department Paris

Sponsors (2)

Lead Sponsor Collaborator
French Cardiology Society Fondation Coeur et Artères

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Recruiting NCT03947866 - Ezetimibe-Rosuvastatin Evaluation Study
Completed NCT01709513 - Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE) Phase 3
Completed NCT01212900 - Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression Phase 4
Completed NCT00001154 - Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Completed NCT02550288 - A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) Phase 3
Completed NCT03929198 - Translation of Pritikin Program to the Community N/A
Completed NCT04485793 - Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia N/A
Completed NCT02341924 - Validating the "Foods for Health" Portfolio of Functional Food Products N/A
Active, not recruiting NCT02223793 - Vascular Lifestyle-Intervention and Screening in Pharmacy N/A
Completed NCT01934608 - The Effect of Synching Prescription Refills on Adherence N/A
Completed NCT01941836 - Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients Phase 2
Recruiting NCT01705873 - Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen N/A
Completed NCT01670734 - Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects Phase 1
Completed NCT01678521 - Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients N/A
Completed NCT01370603 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) Phase 3
Completed NCT01370590 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) Phase 3
Completed NCT01768403 - Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia N/A
Completed NCT01575171 - Using Nudges to Implement Comparative Effectiveness N/A
Completed NCT01446679 - Special Drug Use-Results Survey of Lipitor Tablets N/A